Chronicle Journal: Finance

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Avianca Holdings S.A. (NY: AVH )

0.8800 USD UNCHANGED
Last Price Updated: 7:54 PM EDT, May 8, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Avianca Holdings S.A.

< Previous 1 2 3 4 5 Next >
First Patient Enrolled in AVITA Therapeutic’s Pivotal Study Evaluating the RECELL System for Repigmentation of Stable Vitiligo
First Patient Enrolled in AVITA Therapeutic’s Pivotal Study Evaluating the RECELL System for Repigmentation of Stable Vitiligo 
From Business Wire News Releases
AVITA Therapeutics to Participate in Upcoming Investor Conferences
AVITA Therapeutics to Participate in Upcoming Investor Conferences 
From Business Wire News Releases
AVITA Therapeutics Provides Company Update and Revised Corporate Presentation
AVITA Therapeutics Provides Company Update and Revised Corporate Presentation 
From Business Wire News Releases
AVITA Therapeutics to Participate at the Canaccord Genuity 40th Annual Growth Conference
AVITA Therapeutics, Inc. (NASDAQ: RCEL) (ASX:AVH), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration... 
From Business Wire News Releases
BARDA to Initiate Procurement of the RECELL® System for Emergency Response Preparedness
AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX:AVH), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for... 
From Business Wire News Releases
AVITA Therapeutics Provides Company Update and Preliminary Unaudited Results for the Fourth Quarter and Fiscal Year 2020
AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX:AVH), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for... 
From Business Wire News Releases
AVITA Medical Files RECELL® System Investigational Device Exemption (IDE) Application with the U.S. Food and Drug Administration for Treatment of Vitiligo
AVITA Medical Limited (ASX: AVH) (NASDAQ: RCEL), a regenerative medicine company with a technology platform positioned to address unmet medical needs in therapeutic skin restoration, today announced... 
From Business Wire News Releases
AVITA Medical to Participate at the Jefferies Virtual Healthcare Conference
AVITA Medical to Participate at the Jefferies Virtual Healthcare Conference 
From Business Wire News Releases
AVITA Medical to Participate at Oppenheimer's MedTech Summit
AVITA Medical to Participate at Oppenheimer's MedTech Summit 
From Business Wire News Releases
Avianca Holdings Takes Important Step Forward In Reorganization
- Company Secures Approval of All Requests at its "First Day" Hearing, Supporting Ongoing Operations 
From PR Newswire
AVITA Medical Limited Proposed Redomiciliation to the United States of America – Registration of Scheme Booklet with ASIC and Financial Reporting Relief Granted by ASIC
AVITA Medical Limited (Company) (ASX:AVH) (NASDAQ:RCEL) is pleased to announce that the Australian Securities and Investments Commission (ASIC) has registered the scheme booklet (Scheme Booklet) in... 
From Business Wire News Releases
AVITA Medical Limited Proposed redomiciliation to the United States of America – Federal Court of Australia orders convening of Scheme Meeting
AVITA Medical Limited Proposed redomiciliation to the United States of America – Federal Court of Australia orders convening of Scheme Meeting 
From Business Wire News Releases
Avianca Holdings Initiates Voluntary Reorganization Proceedings
- Despite Effective Debt Reprofiling in 2019 and Successful Execution of its "Avianca 2021" Plan through Mid-March, Speed and Scale of Dramatic COVID-19 Crisis Impact Necessitates Avianca's Chapter 11... 
From PR Newswire
AVITA Medical Reports Third Quarter Fiscal 2020 Financial Results and Company Update
AVITA Medical Reports Third Quarter Fiscal 2020 Financial Results and Company Update 
From Business Wire News Releases
AVITA Medical Announces Intention to Redomicile to the United States of America
AVITA Medical Announces Intention to Redomicile to the United States of America 
From Business Wire News Releases
AVITA Medical Provides Preliminary Top Line Results for the Third Quarter and COVID-19 Update
AVITA Medical Provides Preliminary Top Line Results for the Third Quarter and COVID-19 Update 
From Business Wire News Releases
RECELL® System Data Accepted to 52nd Annual American Burn Association Meeting Available Online
RECELL® System Data Accepted to 52nd Annual American Burn Association Meeting Available Online 
From Business Wire News Releases
First Patient Enrolled in AVITA Medical’s Pivotal Study Evaluating RECELL® System for Pediatric Scald Injuries
AVITA Medical Limited (ASX: AVH) (NASDAQ: RCEL), a regenerative medicine company with a technology platform positioned to address unmet medical needs in therapeutic skin restoration, announced today... 
From Business Wire News Releases
AVITA Medical to Attend the 2020 BTIG Healthcare Conference
AVITA Medical to Attend the 2020 BTIG Healthcare Conference 
From Business Wire News Releases
First Patient Enrolled in AVITA Medical’s Pivotal Study Evaluating RECELL System for Soft Tissue Reconstruction
AVITA Medical Limited (ASX: AVH, NASDAQ: RCEL), a regenerative medicine company with a technology platform positioned to address unmet medical needs in therapeutic skin restoration, announced today the... 
From Business Wire News Releases
AVITA Medical Half-Year Financial Report for Fiscal 2020
AVITA Medical Limited (ASX: AVH, NASDAQ: RCEL), a regenerative medicine company with a technology platform positioned to address unmet medical needs in therapeutic skin restoration, announced that it... 
From Business Wire News Releases
AVITA Medical to Present at the Cowen 40th Annual Health Care Conference
AVITA Medical (ASX: AVH) (NASDAQ: RCEL), a global regenerative medicine company, announced that management will present at the Cowen 40th Annual Health Care Conference in Boston. The presentation is... 
From Business Wire News Releases
AVITA Medical Reports Second Quarter Fiscal 2020 Financial Results and Company Update
AVITA Medical Limited (ASX: AVH, NASDAQ: RCEL), a regenerative medicine company with a technology platform positioned to address unmet medical needs in therapeutic skin restoration, reported financial... 
From Business Wire News Releases
Avianca Holdings Announces Fleet Plan Optimization
As part of the implementation of the "Avianca 2021 Plan", Avianca management has reached the following agreements to tailor its aircraft commitments to its future requirements: 
From PR Newswire
AVITA Medical Receives U.S. FDA Investigational Device Exemption Approval of Clinical Feasibility Study to Evaluate RECELL System for Vitiligo
AVITA Medical Limited (ASX: AVH, NASDAQ: RCEL), a regenerative medicine company with a technology platform positioned to address unmet medical needs in therapeutic skin restoration, announced today... 
From Business Wire News Releases
Avianca Airlines partners with FirstHive to better understand customer behavior
From ACN Newswire
Avianca Airlines partners with FirstHive to better understand its customer behavior
From ACN Newswire
AVITA Medical and the Gates Center for Regenerative Medicine at the University of Colorado Anschutz Medical Campus Enter into Collaboration to Explore Potential Spray-On Treatment of Genetically Modif
AVITA Medical (ASX: AVH, NASDAQ: RCEL), a regenerative medicine company with a technology platform positioned to address unmet medical needs in therapeutic skin restoration, and scientists at the Gates... 
From Business Wire News Releases
AVITA Medical Names David McIntyre as Chief Financial Officer
AVITA Medical (ASX: AVH, NASDAQ: RCEL), a regenerative medicine company with a technology platform positioned to address unmet medical needs in therapeutic skin restoration, announced today the... 
From Business Wire News Releases
AVITA Medical Announces Institutional Placement of A$120.0 Million to Support Commercial Growth and Pipeline Development
AVITA Medical (ASX: AVH, NASDAQ: RCEL), a regenerative medicine company with a technology platform positioned to address unmet medical needs in therapeutic skin restoration, announced today an... 
From Business Wire News Releases
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

© Copyright 2015, Chronicle Journal, Thunder Bay, ON. Powered by BLOX Content Management System from TownNews.com. [Terms of Use | Privacy Policy]